nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC18A1—Amine compound SLC transporters—SLC14A2—rectum cancer	0.113	0.261	CbGpPWpGaD
Methamphetamine—SLC6A2—autonomic nervous system—rectum cancer	0.0517	0.0913	CbGeAlD
Methamphetamine—SLC18A2—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0462	0.106	CbGpPWpGaD
Methamphetamine—SLC18A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0442	0.102	CbGpPWpGaD
Methamphetamine—TAAR1—female reproductive system—rectum cancer	0.0398	0.0703	CbGeAlD
Methamphetamine—SLC18A1—vagina—rectum cancer	0.0383	0.0676	CbGeAlD
Methamphetamine—SLC6A2—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0311	0.0716	CbGpPWpGaD
Methamphetamine—SLC6A3—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0275	0.0635	CbGpPWpGaD
Methamphetamine—SLC18A1—lymph node—rectum cancer	0.0248	0.0437	CbGeAlD
Methamphetamine—SLC18A1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.0201	0.0463	CbGpPWpGaD
Methamphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0181	0.0416	CbGpPWpGaD
Methamphetamine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0156	0.036	CbGpPWpGaD
Methamphetamine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0156	0.0359	CbGpPWpGaD
Methamphetamine—SLC22A3—seminal vesicle—rectum cancer	0.0149	0.0264	CbGeAlD
Methamphetamine—MAOB—seminal vesicle—rectum cancer	0.0138	0.0244	CbGeAlD
Methamphetamine—SLC18A2—female reproductive system—rectum cancer	0.0135	0.0239	CbGeAlD
Methamphetamine—SLC22A3—smooth muscle tissue—rectum cancer	0.0125	0.0221	CbGeAlD
Methamphetamine—SLC18A2—vagina—rectum cancer	0.0122	0.0216	CbGeAlD
Methamphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0121	0.028	CbGpPWpGaD
Methamphetamine—SLC22A3—renal system—rectum cancer	0.012	0.0212	CbGeAlD
Methamphetamine—SLC22A3—urethra—rectum cancer	0.0118	0.0209	CbGeAlD
Methamphetamine—MAOA—seminal vesicle—rectum cancer	0.0118	0.0208	CbGeAlD
Methamphetamine—ADRA2C—seminal vesicle—rectum cancer	0.0113	0.02	CbGeAlD
Methamphetamine—SLC22A3—mammalian vulva—rectum cancer	0.0112	0.0199	CbGeAlD
Methamphetamine—MAOB—renal system—rectum cancer	0.0111	0.0197	CbGeAlD
Methamphetamine—MAOB—urethra—rectum cancer	0.0109	0.0193	CbGeAlD
Methamphetamine—SLC22A5—seminal vesicle—rectum cancer	0.0109	0.0192	CbGeAlD
Methamphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0108	0.0248	CbGpPWpGaD
Methamphetamine—MAOB—mammalian vulva—rectum cancer	0.0104	0.0184	CbGeAlD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.0102	0.0235	CbGpPWpGaD
Methamphetamine—SLC22A3—female reproductive system—rectum cancer	0.00963	0.017	CbGeAlD
Methamphetamine—MAOA—renal system—rectum cancer	0.0095	0.0168	CbGeAlD
Methamphetamine—SLC6A4—female reproductive system—rectum cancer	0.00938	0.0166	CbGeAlD
Methamphetamine—MAOA—urethra—rectum cancer	0.00933	0.0165	CbGeAlD
Methamphetamine—ADRA2C—renal system—rectum cancer	0.00913	0.0161	CbGeAlD
Methamphetamine—ADRA2A—seminal vesicle—rectum cancer	0.00904	0.016	CbGeAlD
Methamphetamine—ADRA2C—urethra—rectum cancer	0.00897	0.0158	CbGeAlD
Methamphetamine—MAOB—female reproductive system—rectum cancer	0.00891	0.0157	CbGeAlD
Methamphetamine—MAOA—mammalian vulva—rectum cancer	0.00888	0.0157	CbGeAlD
Methamphetamine—SLC22A5—renal system—rectum cancer	0.00875	0.0154	CbGeAlD
Methamphetamine—SLC22A3—vagina—rectum cancer	0.00871	0.0154	CbGeAlD
Methamphetamine—SLC22A5—urethra—rectum cancer	0.00859	0.0152	CbGeAlD
Methamphetamine—ADRA2C—mammalian vulva—rectum cancer	0.00854	0.0151	CbGeAlD
Methamphetamine—SLC6A2—female reproductive system—rectum cancer	0.00826	0.0146	CbGeAlD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.0082	0.0189	CbGpPWpGaD
Methamphetamine—MAOB—vagina—rectum cancer	0.00806	0.0142	CbGeAlD
Methamphetamine—SLC18A2—lymph node—rectum cancer	0.00791	0.014	CbGeAlD
Methamphetamine—MAOA—female reproductive system—rectum cancer	0.00761	0.0134	CbGeAlD
Methamphetamine—ADRA2A—urethra—rectum cancer	0.00716	0.0126	CbGeAlD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00709	0.0164	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00707	0.0163	CbGpPWpGaD
Methamphetamine—SLC22A5—female reproductive system—rectum cancer	0.007	0.0124	CbGeAlD
Methamphetamine—MAOA—vagina—rectum cancer	0.00688	0.0121	CbGeAlD
Methamphetamine—ADRA2A—mammalian vulva—rectum cancer	0.00681	0.012	CbGeAlD
Methamphetamine—ADRA2C—vagina—rectum cancer	0.00661	0.0117	CbGeAlD
Methamphetamine—SLC22A5—vagina—rectum cancer	0.00634	0.0112	CbGeAlD
Methamphetamine—ADRA2A—female reproductive system—rectum cancer	0.00584	0.0103	CbGeAlD
Methamphetamine—CYP2D6—renal system—rectum cancer	0.00564	0.00997	CbGeAlD
Methamphetamine—SLC22A3—lymph node—rectum cancer	0.00564	0.00995	CbGeAlD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00552	0.0127	CbGpPWpGaD
Methamphetamine—ADRA2A—vagina—rectum cancer	0.00528	0.00932	CbGeAlD
Methamphetamine—MAOB—lymph node—rectum cancer	0.00521	0.00921	CbGeAlD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00489	0.0113	CbGpPWpGaD
Methamphetamine—SLC6A2—lymph node—rectum cancer	0.00483	0.00853	CbGeAlD
Methamphetamine—CYP2D6—female reproductive system—rectum cancer	0.00452	0.00798	CbGeAlD
Methamphetamine—MAOA—lymph node—rectum cancer	0.00445	0.00786	CbGeAlD
Methamphetamine—ADRA2C—lymph node—rectum cancer	0.00428	0.00755	CbGeAlD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00417	0.00961	CbGpPWpGaD
Methamphetamine—SLC22A5—lymph node—rectum cancer	0.0041	0.00724	CbGeAlD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00361	0.00831	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00359	0.00829	CbGpPWpGaD
Methamphetamine—ADRA2A—lymph node—rectum cancer	0.00341	0.00603	CbGeAlD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00281	0.00647	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00249	0.00573	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—TYMS—rectum cancer	0.00216	0.00498	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—ITGA2—rectum cancer	0.00115	0.00265	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—ITGA2—rectum cancer	0.00107	0.00247	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000879	0.00203	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—ITGA2—rectum cancer	0.000872	0.00201	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—TP53—rectum cancer	0.000716	0.00165	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—NRAS—rectum cancer	0.000673	0.00155	CbGpPWpGaD
Methamphetamine—SLC18A2—Neuronal System—HRAS—rectum cancer	0.000673	0.00155	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—KRAS—rectum cancer	0.00058	0.00134	CbGpPWpGaD
Methamphetamine—MAOA—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000564	0.0013	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—TYMS—rectum cancer	0.000546	0.00126	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000524	0.00121	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HRAS—rectum cancer	0.000493	0.00114	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—TYMS—rectum cancer	0.000462	0.00107	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—HRAS—rectum cancer	0.000432	0.000996	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—HRAS—rectum cancer	0.000401	0.000925	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NRAS—rectum cancer	0.000398	0.000917	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—TYMS—rectum cancer	0.000343	0.000791	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—KRAS—rectum cancer	0.000342	0.000789	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—NRAS—rectum cancer	0.000323	0.000744	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—rectum cancer	0.000304	0.000702	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NRAS—rectum cancer	0.000302	0.000695	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HRAS—rectum cancer	0.000291	0.000671	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TYMS—rectum cancer	0.000282	0.00065	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—KRAS—rectum cancer	0.000278	0.000641	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—KRAS—rectum cancer	0.00026	0.000599	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—rectum cancer	0.000247	0.000569	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NRAS—rectum cancer	0.000245	0.000565	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HRAS—rectum cancer	0.000236	0.000545	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—rectum cancer	0.000231	0.000532	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TYMS—rectum cancer	0.000229	0.000528	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HRAS—rectum cancer	0.000221	0.000509	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—KRAS—rectum cancer	0.000211	0.000486	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—rectum cancer	0.000187	0.000432	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—NRAS—rectum cancer	0.000185	0.000427	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HRAS—rectum cancer	0.000179	0.000413	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—NRAS—rectum cancer	0.000173	0.000399	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—KRAS—rectum cancer	0.000159	0.000368	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TYMS—rectum cancer	0.000149	0.000344	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—KRAS—rectum cancer	0.000149	0.000343	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—NRAS—rectum cancer	0.000141	0.000324	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HRAS—rectum cancer	0.000136	0.000313	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HRAS—rectum cancer	0.000127	0.000292	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—KRAS—rectum cancer	0.000121	0.000279	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NRAS—rectum cancer	0.000109	0.000252	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HRAS—rectum cancer	0.000103	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NRAS—rectum cancer	0.000102	0.000236	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KRAS—rectum cancer	9.42e-05	0.000217	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KRAS—rectum cancer	8.8e-05	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—rectum cancer	8.37e-05	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NRAS—rectum cancer	8.3e-05	0.000191	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HRAS—rectum cancer	8.01e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—rectum cancer	7.82e-05	0.00018	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HRAS—rectum cancer	7.48e-05	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KRAS—rectum cancer	7.15e-05	0.000165	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—rectum cancer	6.35e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRAS—rectum cancer	6.08e-05	0.00014	CbGpPWpGaD
